Why the study?
Does nonobstructive coronary artery disease compared to obstructive coronary artery disease affect the risk of death or major cardiovascular events in patients with acute coronary syndrome?
Does nonobstructive coronary artery disease compared to obstructive coronary artery disease affect the risk of death or major cardiovascular events in patients with acute coronary syndrome?
Patients with acute coronary syndrome and nonobstructive coronary artery disease have a significantly lower risk of death and major cardiovascular events compared to those with obstructive disease, though their absolute risk remains substantial.
No takes yet. Share an insight, caveat, or question.
NObCAD signals lower event risk than ObCAD in ACS; reinforces angiographic severity for prognostic stratification and future trials.
Pizzi et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: